![]() Aravive Aravive is a clinical-stage biotechnology company developing therapies for solid tumors and hematologic malignancies. | ![]() Molecular Templates Molecular Templates (MTEM) is a biopharmaceutical company focused on the discovery and development of differentiated, targeted, biologic therapeutics for cancer. | ![]() HEPHAISTOS-Pharma HEPHAISTOS-Pharma is a biotechnology company developing anti-tumor immunotherapies. | ![]() Oncomatryx Oncomatryx Biopharma is a biopharmaceutical company focused on the tumor microenvironment. | |||
Founding Date | Founding Date 2008 | Founding Date 2009 | Founding Date 2016 | Founding Date 2016 | Founding Date 2018 | Founding Date 2009 |
Type | Type Public | Type Public | Type Private | Type Private | Type Private | Type Private |
Tags | ||||||
Locations | Locations Houston, US HQ | Locations Austin, US HQ New York, US | Locations Houston, US HQ | Locations HQ | Locations Orsay, FR HQ | Locations HQ |
Employees | Employees 23 | Employees 6272% decrease | Employees 2 | Employees N/A | Employees 15 | Employees 274% increase |
Valuation ($) | Valuation ($) 2.9 m | Valuation ($) 3.3 m | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) N/A |
Financial | ||||||
Revenue (est.) | Revenue (est.) $9.1m (FY, 2022) | Revenue (est.) $57.3m (FY, 2023) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) N/A |
Net income | Net income ($76.3m) (FY, 2022) | Net income ($8.1m) (FY, 2023) | Net income N/A | Net income N/A | Net income N/A | Net income N/A |
Funding | ||||||
Latest funding round | Latest funding round N/A | Latest funding round N/A | Latest funding round $ 17m (over 9 years ago) | Latest funding round $ 17.8m (over 6 years ago) | Latest funding round N/A | Latest funding round $ 4.9m (over 10 years ago) |
Total funding raised | Total funding raised N/A | Total funding raised $ 89.6m | Total funding raised $ 17m | Total funding raised $ 17.8m | Total funding raised N/A | Total funding raised $ 4.9m |

Molecular Templates (MTEM) is a biopharmaceutical company focused on the discovery and development of differentiated, targeted, biologic therapeutics for cancer.
View company
Affigen is a company that specializes in producing research and diagnostic reagents.
View company
HEPHAISTOS-Pharma is a biotechnology company developing anti-tumor immunotherapies.
View company